Vaxcyte (PCVX) Receivables - Net (2019 - 2025)
Vaxcyte (PCVX) reported Receivables - Net of $400000.0 for Q3 2025, up 33.33% year-over-year from $300000.0 in Q3 2024, and up 300.0% quarter-over-quarter from $100000.0 in Q2 2025.
Vaxcyte (PCVX) Receivables - Net (2019 - 2025) Analysis & Trends
Vaxcyte (PCVX) has 7 years of Receivables - Net data on file, last reported at $400000.0 in Q3 2025.
- Receivables - Net for Q3 2025 came in at $400000.0, up 33.33% year-over-year; the trailing twelve-month figure through Sep 2025 was $400000.0 (up 33.33% YoY), and the FY2024 annual result was $400000.0, changed N/A from the prior year.
- Receivables - Net rose to $400000.0 in Q3 2025 per PCVX's latest filing, from $100000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $5.0 million in Q3 2021 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $1.0 million and a median of $400000.0 in 2021 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2021 and 2022: Receivables - Net soared 525.0% in 2021, then plunged 86.0% in 2022.
- A 5-year view of Receivables - Net shows it stood at $1.2 million in 2021, then declined by 16.67% to $1.0 million in 2022, then soared by 90.0% to $1.9 million in 2023, then sank by 78.95% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
- Business Quant data shows PCVX's Receivables - Net at $400000.0 in Q3 2025, $100000.0 in Q2 2025, and $400000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Sep 30, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.90 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |